We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.1B
AUM Growth
+$628M
(+2.2%)
Cap. Flow
-$702M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
22.73%
Holding
1,138
New
91
Increased
498
Reduced
344
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$407M |
| 2 |
DexCom
DXCM
|
+$326M |
| 3 |
Roper Technologies
ROP
|
+$288M |
| 4 |
PayPal
PYPL
|
+$238M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$498M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$448M |
| 3 |
Fastenal
FAST
|
+$296M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$175M |
| 5 |
Amazon
AMZN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Healthcare | 14.35% |
| 3 | Financials | 13.74% |
| 4 | Consumer Discretionary | 12.34% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
DaVita
DVA
$15.2B
| $330M | 1.13% |
4,988,238
+437,015
| +10% | +$30.8M |
|
|
27
DexCom
DXCM
$28.3B
| $321M | 1.1% |
14,637,224
+14,626,980
| +142,786% | +$326M |
|
28
Akamai
AKAM
$16.4B
| $314M | 1.08% |
5,922,343
-116,031
| -2% | -$6.21M |
|
29
Cognizant
CTSH
$22.3B
| $312M | 1.07% |
6,545,700
+315,113
| +5% | +$17.9M |
|
|
30
Roper Technologies
ROP
$37.1B
| $312M | 1.07% |
1,711,473
+1,652,951
| +2,824% | +$288M |
|
31
Mastercard
MA
$487B
| $301M | 1.04% |
2,961,923
+13,591
| +0.5% | +$1.3M |
|
32
Apple
AAPL
$4.95T
| $273M | 0.94% |
9,658,972
-332,504
| -3% | -$8.8M |
|
|
ANSS
33
DELISTED
Ansys
ANSS
| $271M | 0.93% |
2,926,291
-196,041
| -6% | -$18.3M |
|
34
Microsoft
MSFT
$2.89T
| $267M | 0.92% |
4,636,866
+50,365
| +1% | +$2.84M |
|
35
Berkshire Hathaway Class B
BRK.B
$1.07T
| $249M | 0.86% |
1,724,786
+20,375
| +1% | +$2.98M |
|
36
ExxonMobil
XOM
$642B
| $248M | 0.85% |
2,846,247
+6,896
| +0.2% | +$612K |
|
37
Wells Fargo
WFC
$264B
| $223M | 0.77% |
5,036,053
+156,446
| +3% | +$7.49M |
|
38
Under Armour Class C
UA
$2.95B
| $204M | 0.7% |
6,035,414
-381,547
| -6% | -$13.8M |
|
39
Edwards Lifesciences
EW
$47.8B
| $196M | 0.67% |
4,878,195
-63,816
| -1% | -$2.4M |
|
40
Booking.com
BKNG
$145B
| $191M | 0.66% |
3,246,925
-158,700
| -5% | -$8.85M |
|
41
CarMax
KMX
$8.29B
| $184M | 0.63% |
3,443,088
-28,758
| -0.8% | -$1.63M |
|
42
JPMorgan Chase
JPM
$947B
| $181M | 0.62% |
2,725,576
-64,863
| -2% | -$4.23M |
|
|
SCHW
43
Charles Schwab
SCHW
$181B
| $173M | 0.6% |
5,489,845
-5,982,866
| -52% | -$175M |
|
44
Kinder Morgan
KMI
$70.6B
| $173M | 0.59% |
7,478,246
-64,900
| -0.9% | -$1.38M |
|
45
Qualcomm
QCOM
$179B
| $171M | 0.59% |
2,498,012
-35,315
| -1% | -$2.15M |
|
46
Lowe's Companies
LOW
$119B
| $168M | 0.58% |
2,319,738
-4,755
| -0.2% | -$370K |
|
47
State Street SPDR S&P 500 ETF Trust
SPY
$781B
| $162M | 0.56% |
750,828
+138,505
| +23% | +$29.9M |
|
48
Canadian National Railway
CNI
$78B
| $161M | 0.55% |
2,467,815
-299,936
| -11% | -$18.9M |
|
49
Teva Pharmaceuticals
TEVA
$36.2B
| $159M | 0.55% |
3,460,504
-23,642
| -0.7% | -$1.23M |
|
|
ESRX
50
DELISTED
Express Scripts Holding Company
ESRX
| $159M | 0.55% |
2,251,529
-5,991,780
| -73% | -$448M |
|
Similar funds
QCM
Brown Advisory's Q3 2016 Portfolio in Review
As of Q3 2016, Brown Advisory held 1,138 positions worth $29.1B, up 2.2% from $28.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brown Advisory's Q3 2016 filing shows 91 new, 498 increased, 344 reduced and 68 closed positions. Its largest new stake was Fortive: 12,666,674 shares worth $407M. The largest sale was Bristol-Myers Squibb, an estimated $498M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q3 2016 buy was Fortive: 12,666,674 shares worth $407M.
- Brown Advisory added most to DexCom in Q3 2016, an estimated $326M increase.
- Brown Advisory's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $498M.
- Brown Advisory fully exited DIAMOND RESORTS INTL, INC in Q3 2016, selling an estimated $53.1M.
- Brown Advisory's ten largest holdings make up 23% of its $29.1B portfolio in Q3 2016.
- Brown Advisory opened 91 new positions and closed 68 in Q3 2016.
- Brown Advisory's portfolio value rose 2.2% quarter-over-quarter to $29.1B.
Based on Brown Advisory's 13F filing for Q3 2016, filed 14 Nov 2016.